Physician profile
Michael John Wheatley
NPI 1376658773
$198,305.91
in general payments reported to CMS, 2019-2025
7 companies · $11K in 2025
The $11K reported for 2025 was more than what 95% of Surgery of The Hand (Plastic Surgery) providers received nationally (typical 2025 total: $312).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $11K · 2020: $3,142 · 2021: $41K · 2022: $83K · 2023: $31K · 2024: $18K · 2025: $11K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $25K · Honoraria: $15K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $10K · Travel and Lodging: $9,636 · Food and Beverage: $1,134.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $25,182.00 |
| Honoraria | $14,500.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $10,350.00 |
| Travel and Lodging | $9,636.19 |
| Food and Beverage | $1,134.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Microaire Surgical Instruments LLC | $190,363.35 | 2019-2025 | Smart Release |
| Trimed, INC. | $3,535.17 | 2019-2023 | |
| Steelhead Surgical INC | $2,713.87 | 2019-2021 | |
| Acumed LLC | $1,375.00 | 2019 | |
| Arthrex, INC. | $213.66 | 2019 | |
| Depuy Synthes Sales INC. | $92.08 | 2025 | Va-Lcp |
| Endo Pharmaceuticals INC. | $12.78 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Wheatley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.